Clinical trials
Completed Phase 2 Blepharitis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2009 | 3 |
| 2010 | 1 |
| 2014 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Merck Sharp & Dohme LLC | 2 |
| Nicox Ophthalmics, Inc. | 2 |
| Federal University of São Paulo | 1 |
| Galderma R&D | 1 |
| Kala Pharmaceuticals, Inc. | 1 |
| Laboratoires Thea | 1 |
| Tarsus Pharmaceuticals, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Blepharitis | 9 |
| Meibomian Gland Dysfunction | 2 |
| Dry Eye Syndromes | 1 |
| Meibomitis | 1 |
| Mite Infestations | 1 |
| Pain | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.